1054643-14-9

Upstream product

• 188010-90-4 1,5-anhydro-6-O-benzyl-3,4-O-carbonate-2-deoxy-D-lyxo-hex-1-enopyranose 
• 149847-26-7 3,4-o-carbonyl-D-galactal 
• 100-39-0 benzyl bromide 

Downstream Products

• 202657-36-1 (3aS,4R,6S,7R,7aR)-6-((2R,3S,4R)-4-Benzyloxy-2-benzyloxymethyl-3,4-dihydro-2H-pyran-3-yloxy)-4-benzyloxymethyl-7-hydroxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2-one 
• 202657-33-8 (3aS,4R,6S,7R,7aR)-4-Benzyloxymethyl-6-((2R,3R,4R)-2-benzyloxymethyl-4-triethylsilanyloxy-3,4-dihydro-2H-pyran-3-yloxy)-7-hydroxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2-one 
• 322648-63-5 (3aS,4R,6R,7R,7aR)-4-Benzyloxymethyl-6-((2R,3S,4R)-2-benzyloxymethyl-3-triethylsilanyloxy-3,4-dihydro-2H-pyran-4-yloxy)-7-hydroxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2-one 
• 322648-64-6 (3aS,4R,6R,7R,7aS)-7-Benzyloxy-4-benzyloxymethyl-6-((2R,3S,4R)-2-benzyloxymethyl-3-triethylsilanyloxy-3,4-dihydro-2H-pyran-4-yloxy)-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2-one 
• 322648-65-7 N-[(2S,3S,4S,5R,6R)-4-((3aS,4R,6S,7R,7aS)-7-Benzyloxy-4-benzyloxymethyl-2-oxo-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yloxy)-6-benzyloxymethyl-3-iodo-5-triethylsilanyloxy-tetrahydro-pyran-2-yl]-benzenesulfonamide 
• 202657-40-7 C₇₄H₈₉NO₂₂SSi 
• 202657-52-1 (2R,3R,4S,5R,6S)-2-Benzyloxymethyl-6-((2R,3R,4R)-2-benzyloxymethyl-4-triethylsilanyloxy-3,4-dihydro-2H-pyran-3-yloxy)-tetrahydro-pyran-3,4,5-triol 
• 202657-37-2 (2S,3R,4S,5R,6R)-2-((2R,3S,4R)-4-Benzyloxy-2-benzyloxymethyl-3,4-dihydro-2H-pyran-3-yloxy)-6-benzyloxymethyl-tetrahydro-pyran-3,4,5-triol 
• 202657-35-0 (3aS,4R,6S,7R,7aS)-4-Benzyloxymethyl-6-((2R,3R,4R)-2-benzyloxymethyl-4-triethylsilanyloxy-3,4-dihydro-2H-pyran-3-yloxy)-7-triethylsilanyloxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2-one 
• 202657-34-9 Acetic acid (3aS,4R,6S,7R,7aS)-4-benzyloxymethyl-6-((2R,3R,4R)-2-benzyloxymethyl-4-triethylsilanyloxy-3,4-dihydro-2H-pyran-3-yloxy)-2-oxo-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl ester 
• 202657-38-3 Acetic acid (3aS,4R,6S,7R,7aS)-6-((2R,3R,4S,5S,6S)-6-benzenesulfonylamino-2-benzyloxymethyl-5-iodo-4-triethylsilanyloxy-tetrahydro-pyran-3-yloxy)-4-benzyloxymethyl-2-oxo-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl ester 
• 202657-39-4 Acetic acid (3aS,4R,6S,7R,7aS)-6-((2R,3R,4R,5R,6S)-5-benzenesulfonylamino-2-benzyloxymethyl-6-ethylsulfanyl-4-triethylsilanyloxy-tetrahydro-pyran-3-yloxy)-4-benzyloxymethyl-2-oxo-tetrahydro-[1,3]dioxolo[4,5-c]pyran-7-yl ester 
• 202657-44-1 N-[(2S,3S,4S,5R,6R)-6-Benzyloxymethyl-5-((3aS,4R,6S,7R,7aS)-4-benzyloxymethyl-2-oxo-7-triethylsilanyloxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yloxy)-3-iodo-4-triethylsilanyloxy-tetrahydro-pyran-2-yl]-benzenesulfonamide 
• 202657-45-2 N-[(2S,3R,4R,5R,6R)-6-Benzyloxymethyl-5-((3aS,4R,6S,7R,7aS)-4-benzyloxymethyl-2-oxo-7-triethylsilanyloxy-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yloxy)-2-ethylsulfanyl-4-triethylsilanyloxy-tetrahydro-pyran-3-yl]-benzenesulfonamide 

Relevant academic research and scientific papers

Total syntheses of tumor-related antigens N3: Probing the feasibility limits of the glycal assembly method

The total syntheses of two octasaccharide antigens isolated from human milk, 1 and 2, and their corresponding allyl glycosides, 3 and 4, have been achieved by utilizing the glycal method. Convergent assembly of the core hexasaccharides and concurrent intr

Strategy in oligosaccharide synthesis: An application to a concise total synthesis of the KH-1(adenocarcinoma) Antigen

A concise and potentially practical synthesis of the title compound has been achieved. The route features a high degree of convergence and economy of synthetic operations. A key step is the concurrent introductory addition of three α-1-fucosyl residues at